There are over two million new cases of breast cancer a year in the world and 0.6 million deaths. About a third of all early breast cancer cases will become metastatic even with the best [more]
Efforts to improve symptom control near the end of life have received more attention in recent years, but the impact is often frustratingly small. Simon Crompton asks where we are going wrong. Seven years ago, [more]
It makes no sense to perform clinical research that has no relevance to patient care, so why do we do it, and how can we stop? John Ioannidis ponders the problem and offers some suggestions. [more]
P Hadji, R E. Coleman, C Wilson et al. (2016) Adjuvant bisphosphonates in early breast cancer: consensus guidance for clinical practice from a European Panel. Ann Oncol 2016, 27:379–90 Bisphosphonates should be considered as part [more]
As researchers, regulatory bodies and health systems give patients more of a voice in consultation and decision making, advocacy groups are questioning what it really means to represent the patient view. Simon Crompton reports. Nothing [more]
Her campaign to bring a human touch to healthcare, which she carries on even through the tough final stages of cancer, has had widespread impact and brought international acclaim. Simon Crompton talked to the woman [more]
As the European Commission issues its first call for proposals to set up European reference networks, Anna Wagstaff asks: how can these cross-border healthcare structures improve the quality of care received by the almost half [more]
The world is experiencing new and powerful forces in global health, from the Sustainable Development Goals, and ‘grand convergences’ to what is now the central totem in global health – universal health coverage. For cancer [more]